Skip to main content

MILLENNIUM MANAGEMENT LLC

Position in AKBA — Akebia Therapeutics, Inc.

CIK 1273087 NEW YORK, NY

Position in AKBA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$3,314,751
+$652,666 QoQ
Shares Held
2,384,713
+44.2% QoQ
Ownership
0.861%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Derivatives in AKBA

reported options exposure · as of Mar 31, 2022
CallValue
$502,600
CallShares
700,000
PutValue
$73,092
PutShares
101,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

MILLENNIUM MANAGEMENT LLC holds $1,129,364,857 across 44 Drug Manufacturers - Specialty & Generic names. AKBA ranks #24 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AKBA

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,314,751 2,384,713
2025-12-31 $2,662,085 1,653,469
2025-09-30 $7,800,257 2,857,237
2025-06-30 $7,875,136 2,163,499
2025-03-31 $2,311,395 1,203,852
2024-12-31 $322,329 169,647
2024-09-30 $26,723 20,245
2024-06-30 $46,598 45,685
2024-03-31 $5,976,780 3,266,000
2023-12-31 $3,223,983 2,599,987
2023-09-30 $3,480,106 3,052,725
2023-06-30 $1,835,451 2,005,958
2023-03-31 $511 910,958
2022-12-31 $775 1,342,422
2022-09-30 $1,099,951 3,480,858
2022-06-30 $1,890,023 5,354,175
2022-03-31 $73,092 101,800
2022-03-31 $502,600 700,000
2022-03-31 $1,889,642 2,631,814
2021-12-31 $4,347,864 1,923,834
2021-06-30 $1,004,175 264,954
2021-06-30 $379,000 100,000
2021-03-31 $507,750 150,000
2021-03-31 $4,563,971 1,348,293
2020-12-31 $1,680,000 600,000
2020-12-31 $5,450,219 1,946,507
2020-09-30 $5,540,267 2,207,278
2020-03-31 $6,520,429 860,215